Last edition
News about "Arpit Bhatia, Managing Director, Laborate Pharmace"
Laborate's Aqualab Eyes INR 250 Crore with Retail-First Model by FY 25-26
Since its inception in 2022, Laborate’s direct-to-retail division, Aqualab, has reported consistent year-on-year growth, moving from INR 76 crore in FY 2022–23 to INR 108 crore in FY 2023–24.
Arpit Bhatia, Managing Director, Laborate Pharmace | 27/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members